Self-managed vs Supervised Exercise for Knee OA

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorMarius Henriksen

About this trial

Knee osteoarthritis (OA) is a common painful condition associated with pain and disability. OA healthcare costs the Danish society 4.6 billion DKK more per year than the non-OA population and we lack evidence on how best to organize and deliver care to reduce costs. Recommended first line treatment for knee OA is exercise with proven effects on symptoms. The current paradigm assumes that exercise needs to be delivered and supervised by a physiotherapist which require patients to attend a clinic at specific times and geographical locations. This is an expensive model of care and creates barriers for people that are active on the labor market or lives in remote areas with long distances to the nearest clinic. In fact, the productivity loss in Denmark associated with OA is estimated to be 12.4 billion DKK per year.

While effective on symptoms, the current model with supervised physiotherapy associates with significant shortcomings, and barriers related to patient heterogeneity, costs, accessibility, and work absenteeism.

As an alternative, a local fitness center is far more accessible as these are widely dispersed across the country, are accessible daily (including weekends) at all hours, is cheap and offers a wide variety of exercise types, classes, and equipment to accommodate individual preferences. The cost of a fitness center membership is approximately 300 DKK per month and includes exercise ad libitum. In contrast, a typical physiotherapist-supervised exercise program costs 3-4,000 DKK for a 2-month treatment with 2 weekly sessions.

Consequently, there is a need to investigate if self-managed exercise in a fitness center is cost-effective as first-line management of knee OA. To answer this question, the present trial aims to compare self-managed exercise in a fitness center to the current standard - supervised exercise. This has the potential to improve quality of care for people with knee OA by adding a cost-effective option for first line management of people with knee OA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Completion of a supervised therapeutic exercise program for knee OA within 3 months

Contraindication to exercise (e.g., resting systolic blood pressure > 200 or diastolic blood pressure >110 mmHg, acute or reoccurring chest pain, unstable angina. uncontrolled cardiac arrhythmias, decompensated heart failure. suspected or known dissecting aortic aneurysm)

Lack of independent mobility that requires aid for transportation to/from exercise facilities.

Any condition or impairment that, in the opinion of the recruiting GP, makes a potential participant unsuitable for participation or which may obstruct participation (e.g. psychiatric or cognitive disorders, language barriers, or opiate dependency).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Self-managed exercise in a fitness center

    Behavioral

    The participants are offered a 6-month membership of a local fitness club at no cost (paid by the trial). They will receive an introduction to the fitness centre and receive instructions from a personal trainer in the centre to create a personalized exercise programme

  • Supervised Exercise

    Behavioral

    The particiopants are offered participation in the usual care exercise delivered at municipal rehabilitation centers or private physiotherapy clinics, aat the discretion of the referring doctor.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: Self-managed exerciseExperimental treatment 1 intervention
Group B: Physiotherapist-supervised exerciseActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain subscale of the KOOS (Knee injury and Osteoarthritis Outcome Score) questionnaire

Assessed by the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscale (patient-reported questionnaire). The KOOS pain subscale consists of 9 questions with a five-point Likert scale scoring system (ranging from 0 (least severe) to 4 (most severe)). The answers are summed and a 0-100 normalized score is calculated with 0 indicating extreme pain and 100 indicating no pain.

Time frame
Change from baseline after 3 months

Secondary outcomes

1

Health outcome and quality of life survey (EQ-5D-5L)

EQ-5D-5L is a standardized patient-reported instrument for use as a measure of health outcome and quality of life. EQ-5D-5L is designed for self-completion by respondents and is ideally suited for use in surveys.

Time frame
Change from baseline after 3 months
2

Patient Global Assessment of disease impact (PGA)

Patient-reported degree of patient's perceived impact of their knee OA on their overall life will be obtained using a 100 mm analogue scale (VAS) with anchors: 0=" No impact" and 100 = "Worst imaginable impact".

Time frame
Change from baseline after 3 months
3

KOOS Function subscale

Assessed by the Knee injury and Osteoarthritis Outcome Score (KOOS) physical function subscale (patient-reported questionnaire). The KOOS physical function subscale consists of 17 questions with a five-point Likert scale scoring system (ranging from 0 (least severe) to 4 (most severe)). The answers are summed and a 0-100 normalized score is calculated with 0 indicating extreme functional impairment and 100 indicating no functional impairment.

Time frame
Change from baseline after 3 months
4

KOOS quality of Life (QOL) subscale

Assessed by the Knee injury and Osteoarthritis Outcome Score (KOOS) knee related quality of life subscale (patient-reported questionnaire) The KOOS knee related quality of life subscale consists of 4 questions with a five-point Likert scale scoring system (ranging from 0 (least severe) to 4 (most severe)). The answers are summed and a 0-100 normalized score is calculated with 0 indicating extremely poor knee related quality of life pain and 100 indicating very good knee related quality of life .

Time frame
Change from baseline after 3 months

Other outcomes

1

Analgesics usage

The participants' use of over-the-counter paracetamol and ibuprofen will be collected via questionnaire. Analgesics usage is recorded as a response to the questions "How often do you take pain relieving medicine\* for your knee OA pain" with response options 1) Daily; 2) 2-3 times per week: 3) Rarer; or 4) Never. Responses 1 and 2 defines an analgesics user, whereas responses 3 and 4 defines a non-user. \* A list of typical brand names will be provided.

Time frame
After 1, 2, 3, 4, 5, 6 months
2

Sleep Quality Single-item sleep quality scale (SQS)

Sleep quality will be obtained with the global Single-item sleep quality scale (SQS).

Time frame
After 1, 2, 3, 4, 5, 6 months
3

Self-reported physical activity (UCLA activity scale)

Self-reported physical activity will be obtained with the University of California Loas Angeles activity scale (UCLA). UCLA is a single-item 10-level-scale, ranging from level 10, representing a highly physically active patient, to level 1, a patient who is dependent on others and unable to leave home.

Time frame
After 1, 2, 3, 4, 5, 6 months
4

Out of pocket spending on knee OA - The cost for patients questionnaire (CoPaQ)

The cost for patients questionnaire (CoPaQ) is a comprehensive tool to measure direct and indirect out-of-pocket costs of a health condition for patients and their families to various outpatient contexts.

Time frame
After 1, 2, 3, 4, 5, 6 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Marius Henriksen

Lead sponsor

Frederiksberg University Hospital

Sponsor institution

University of Copenhagen

Collaborator

Research Unit for General Practice in Aalborg

Collaborator

This trial is not recruiting at the moment. You can still explore other options: